- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Mangalam Organics has announced a board meeting on May 27, 2025, to consider the financial results for the quarter and half-year.
Revenue Performance: For FY25, consolidated revenue grew to Rs. 530.01 Cr, marking a 7.3% YoY increase led by its Chemicals segment benefiting from higher operational activity.
Profitability and EPS: Net profit surged to Rs. 16.62 Cr from Rs. 3.99 Cr a year ago, a more than fourfold rise. EPS improved sharply to Rs. 19.41 from Rs. 4.92. Margins expanded due to effective cost control despite increased raw material consumption.
Operational Costs: Raw material expenses rose to Rs. 312.47 Cr from Rs. 258.93 Cr, reflecting greater production. Employee costs increased slightly to Rs. 6.87 Cr, while depreciation remained steady. A notable inventory build-up points to stocking ahead of expected demand.
Key Metrics: EBITDA jumped nearly 38% to Rs. 156.40 Cr, pushing operating margins up to around 29.5%. Finance costs increased but were comfortably covered by the strong earnings.
Balance Sheet / Cash Flow Health: Borrowings increased to Rs. 266.92 Cr, funding capex of Rs. 67.27 Cr and inventory expansion. Cash balances dipped to Rs. 0.48 Cr from Rs. 1.74 Cr. Current liabilities rose, reflecting higher working capital needs.
Management Commentary / Strategic Outlook: Capex and inventory growth suggest planned capacity expansion and management’s focus on scaling with anticipated demand.
Final Takeaway: Mangalam Organics’ strong revenue and profit growth backed by operational efficiency and strategic investments indicates positive momentum. Retail investors can consider the stock favorably while keeping an eye on leverage and working capital dynamics.